• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠促胰液素受体第一个胞外环内的赖氨酸173残基参与促胰液素中天冬氨酸3的羧基部分识别。

Lysine 173 residue within the first exoloop of rat secretin receptor is involved in carboxylate moiety recognition of Asp 3 in secretin.

作者信息

Vilardaga J P, di Paolo E, de Neef P, Waelbroeck M, Bollen A, Robberecht P

机构信息

Department of Biochemistry and Nutrition, School of Medicine, Université Libre de Bruxelles, Belgium.

出版信息

Biochem Biophys Res Commun. 1996 Jan 26;218(3):842-6. doi: 10.1006/bbrc.1996.0150.

DOI:10.1006/bbrc.1996.0150
PMID:8579602
Abstract

The contribution of the extracellular loops of the secretin receptor to the recognition of secretin was investigated by transfection in CHO cells of chimeric receptors, in which the three loops of the secretin recombinant receptor were replaced by the corresponding sequences of the glucagon receptor. The role of the third loop could not be evaluated as the transfected cells did not respond to secretin. Replacement of extracellular loop 2 reduced markedly the capability of secretin to occupy the receptor but did not alter the capacity of the receptor to discriminate between peptide analogues modified in position 3. Replacement of the first extracellular loop not only reduced the potency of secretin but also decreased the capacity of the receptor to discriminate between ligands having in position 3 an aspartate (as in secretin), an asparagine, or a glutamic acid. This change in receptor properties was reproduced by a single mutation of lysine 173 of the receptor into isoleucine. Thus, the basic amino acid in position 173 is likely to interact with aspartate 3 of secretin. As an aspartate is also present in position 3 of VIP and PACAP, two peptides related to secretin, and a lysine residue is conserved in the first extracellular loop of the VIP and PACAP receptors, this interaction may be a key element of peptide recognition by this receptor family.

摘要

通过在CHO细胞中对嵌合受体进行转染,研究了促胰液素受体细胞外环对促胰液素识别的贡献。在这些嵌合受体中,促胰液素重组受体的三个环被胰高血糖素受体的相应序列所取代。由于转染细胞对促胰液素无反应,因此无法评估第三环的作用。细胞外环2的替换显著降低了促胰液素占据受体的能力,但并未改变受体区分在第3位修饰的肽类似物的能力。第一细胞外环的替换不仅降低了促胰液素的效力,还降低了受体区分在第3位具有天冬氨酸(如促胰液素中)、天冬酰胺或谷氨酸的配体的能力。受体性质的这种变化可通过将受体的赖氨酸173单突变为异亮氨酸来重现。因此,第173位的碱性氨基酸可能与促胰液素的天冬氨酸3相互作用。由于与促胰液素相关的两种肽——血管活性肠肽(VIP)和垂体腺苷酸环化酶激活肽(PACAP)在第3位也存在天冬氨酸,并且VIP和PACAP受体的第一细胞外环中保守有一个赖氨酸残基,这种相互作用可能是该受体家族识别肽的关键因素。

相似文献

1
Lysine 173 residue within the first exoloop of rat secretin receptor is involved in carboxylate moiety recognition of Asp 3 in secretin.大鼠促胰液素受体第一个胞外环内的赖氨酸173残基参与促胰液素中天冬氨酸3的羧基部分识别。
Biochem Biophys Res Commun. 1996 Jan 26;218(3):842-6. doi: 10.1006/bbrc.1996.0150.
2
Cross-chimeric analysis of selectivity of secretin and VPAC(1) receptor activation.促胰液素和VPAC(1)受体激活选择性的交叉嵌合分析。
J Pharmacol Exp Ther. 2000 Nov;295(2):682-8.
3
Mutational analysis of the glucagon receptor: similarities with the vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide (PACAP)/secretin receptors for recognition of the ligand's third residue.胰高血糖素受体的突变分析:与血管活性肠肽(VIP)/垂体腺苷酸环化酶激活肽(PACAP)/促胰液素受体在识别配体第三个残基方面的相似性。
Biochem J. 2002 Mar 1;362(Pt 2):389-94. doi: 10.1042/0264-6021:3620389.
4
Properties of a recombinant human secretin receptor: a comparison with the rat and rabbit receptors.重组人促胰液素受体的特性:与大鼠和兔受体的比较。
Pancreas. 1999 Jul;19(1):51-5.
5
Structural basis of natural ligand binding and activation of the Class II G-protein-coupled secretin receptor.II类G蛋白偶联促胰液素受体天然配体结合与激活的结构基础
Biochem Soc Trans. 2007 Aug;35(Pt 4):709-12. doi: 10.1042/BST0350709.
6
Molecular basis and species specificity of high affinity binding of vasoactive intestinal polypeptide by the rat secretin receptor.大鼠促胰液素受体对血管活性肠肽高亲和力结合的分子基础及物种特异性
J Pharmacol Exp Ther. 1996 Nov;279(2):555-60.
7
Interaction of amino acid residues at positions 8-15 of secretin with the N-terminal domain of the secretin receptor.促胰液素8-15位氨基酸残基与促胰液素受体N端结构域的相互作用。
Eur J Biochem. 1996 Jul 15;239(2):349-55. doi: 10.1111/j.1432-1033.1996.0349u.x.
8
Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor.VPAC1受体第三螺旋中的Asn229对于受体激活至关重要,但对于受体磷酸化和内化并非必需:与VPAC2受体中的Asn216进行比较。
Cell Signal. 2006 Dec;18(12):2121-30. doi: 10.1016/j.cellsig.2006.03.006. Epub 2006 Mar 27.
9
Properties and regulation of the coupling to adenylate cyclase of secretin receptors stably transfected in Chinese hamster ovary cells.
Mol Pharmacol. 1994 May;45(5):1022-8.
10
Aspartate 196 in the first extracellular loop of the human VIP1 receptor is essential for VIP binding and VIP-stimulated cAMP production.人VIP1受体第一个细胞外环中的天冬氨酸196对于VIP结合及VIP刺激的cAMP产生至关重要。
Biochem Biophys Res Commun. 1997 Jan 13;230(2):289-92. doi: 10.1006/bbrc.1996.5949.

引用本文的文献

1
Use of Cysteine Trapping to Map Spatial Approximations between Residues Contributing to the Helix N-capping Motif of Secretin and Distinct Residues within Each of the Extracellular Loops of Its Receptor.利用半胱氨酸捕获技术绘制促胰液素螺旋N端封帽基序中残基与受体每个细胞外环内不同残基之间的空间近似关系。
J Biol Chem. 2016 Mar 4;291(10):5172-84. doi: 10.1074/jbc.M115.706010. Epub 2016 Jan 6.
2
The peptide agonist-binding site of the glucagon-like peptide-1 (GLP-1) receptor based on site-directed mutagenesis and knowledge-based modelling.基于定点诱变和知识建模的胰高血糖素样肽-1(GLP-1)受体的肽激动剂结合位点
Biosci Rep. 2015 Nov 23;36(1):e00285. doi: 10.1042/BSR20150253.
3
Structural and functional insights into the juxtamembranous amino-terminal tail and extracellular loop regions of class B GPCRs.
对B类G蛋白偶联受体近膜氨基末端尾部和细胞外环区域的结构与功能的见解
Br J Pharmacol. 2014 Mar;171(5):1085-101. doi: 10.1111/bph.12293.
4
Importance of each residue within secretin for receptor binding and biological activity.每个残基在分泌素中对受体结合和生物活性的重要性。
Biochemistry. 2011 Apr 12;50(14):2983-93. doi: 10.1021/bi200133u. Epub 2011 Mar 21.
5
Mutational analysis of the glucagon receptor: similarities with the vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide (PACAP)/secretin receptors for recognition of the ligand's third residue.胰高血糖素受体的突变分析:与血管活性肠肽(VIP)/垂体腺苷酸环化酶激活肽(PACAP)/促胰液素受体在识别配体第三个残基方面的相似性。
Biochem J. 2002 Mar 1;362(Pt 2):389-94. doi: 10.1042/0264-6021:3620389.
6
Mutational analysis of the human vasoactive intestinal peptide receptor subtype VPAC(2): role of basic residues in the second transmembrane helix.人血管活性肠肽受体亚型VPAC(2)的突变分析:第二个跨膜螺旋中碱性残基的作用
Br J Pharmacol. 2001 Aug;133(8):1249-54. doi: 10.1038/sj.bjp.0704195.
7
Characterization of a novel VPAC(1) selective agonist and identification of the receptor domains implicated in the carboxyl-terminal peptide recognition.一种新型VPAC(1)选择性激动剂的表征以及参与羧基末端肽识别的受体结构域的鉴定。
Br J Pharmacol. 2000 Jun;130(4):819-26. doi: 10.1038/sj.bjp.0703384.